{"id":6772,"date":"2026-03-03T16:55:41","date_gmt":"2026-03-03T16:55:41","guid":{"rendered":"https:\/\/helixona.com\/staging\/?page_id=6772"},"modified":"2026-04-02T16:47:32","modified_gmt":"2026-04-02T16:47:32","slug":"lyme-disease-chronic-co-infections-treatment","status":"publish","type":"page","link":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/","title":{"rendered":"Lyme Disease &amp; Chronic Co-Infections"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"6772\" class=\"elementor elementor-6772\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b7b46a7 e-flex e-con-boxed e-con e-parent\" data-id=\"b7b46a7\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;slideshow&quot;,&quot;background_slideshow_gallery&quot;:[{&quot;id&quot;:192,&quot;url&quot;:&quot;https:\\\/\\\/helixona.com\\\/staging\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0fb3e157d1771905b4a71d0e7eda07f6172096ee-1-scaled.jpg&quot;}],&quot;background_slideshow_loop&quot;:&quot;yes&quot;,&quot;background_slideshow_slide_duration&quot;:5000,&quot;background_slideshow_slide_transition&quot;:&quot;fade&quot;,&quot;background_slideshow_transition_duration&quot;:500}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-a133eb7 e-con-full e-flex e-con e-child\" data-id=\"a133eb7\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-1ac4772 e-con-full e-flex e-con e-child\" data-id=\"1ac4772\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2518995 elementor-widget elementor-widget-heading\" data-id=\"2518995\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Lyme Disease &amp; Chronic Co-Infections<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5d0bfbe elementor-widget elementor-widget-button\" data-id=\"5d0bfbe\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-size-sm\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">symptoms we treat<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5a5e725 e-flex e-con-boxed e-con e-parent\" data-id=\"5a5e725\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5fd7639 elementor-widget elementor-widget-html\" data-id=\"5fd7639\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<style>\n  .hx-mcas * { margin: 0; padding: 0; box-sizing: border-box; }\n  .hx-mcas { font-family: 'Open Sans', sans-serif; color: #2D2D2D; line-height: 1.7; max-width: 1200px; margin: 0 auto; padding: 0 20px; }\n  .hx-mcas h1, .hx-mcas h2, .hx-mcas h3, .hx-mcas h4 { font-family: 'TT Ramillas Trial Regular', serif; font-weight: 400; line-height: 1.3; }\n  .hx-mcas .hx-accent { font-family: 'TT Ramillas Trial Regular', serif; color: #C8A876; }\n  .hx-mcas p { font-family: 'Open Sans', sans-serif; font-size: 16px; color: #1a1a1a; font-weight: 300; line-height: 1.8; }\n  .hx-mcas a { text-decoration: none; }\n\n  \/* \u2500\u2500 HERO \u2500\u2500 *\/\n  .hx-mcas-hero { padding: 70px 0 60px; display: flex; gap: 50px; align-items: center; flex-wrap: wrap; }\n  .hx-mcas-hero-image { flex: 0 0 45%; position: relative; }\n  .hx-mcas-hero-image img { width: 100%; height: 500px; object-fit: cover; display: block; border-radius: 4px; }\n  .hx-mcas-hero-image::before { content: ''; position: absolute; top: -12px; left: -12px; width: 100%; height: 100%; border: 1px solid #e0d5c3; border-radius: 4px; z-index: -1; }\n  .hx-mcas-hero-text { flex: 1; min-width: 300px; }\n  .hx-mcas-hero-text .hx-gold-line { width: 60px; height: 2px; background: #C8A876; margin-bottom: 20px; }\n  .hx-mcas-hero-text h1 { font-size: 52px; margin-bottom: 8px; color: #1a1a1a; line-height: 1.15; }\n  .hx-mcas-hero-text .hx-subtitle { font-family: 'TT Ramillas Trial Regular', serif; color: #C8A876; font-size: 20px; margin-bottom: 28px; }\n  .hx-mcas-hero-text p { margin-bottom: 16px; text-align: left; }\n  .hx-mcas-hero-text .hx-highlight { font-weight: 600; color: #1a1a1a; }\n\n  \/* \u2500\u2500 SECTION SPACING \u2500\u2500 *\/\n  .hx-section { padding: 60px 0; }\n  .hx-section-title { text-align: center; font-size: 34px; margin-bottom: 44px; color: #1a1a1a; }\n\n  \/* \u2500\u2500 HOW IT DEVELOPS \u2500\u2500 *\/\n  .hx-develops-intro { text-align: center; max-width: 750px; margin: 0 auto 44px; }\n  .hx-develops-intro p { margin-bottom: 12px; }\n\n  .hx-pathway-flow { display: flex; align-items: flex-start; justify-content: center; gap: 0; flex-wrap: wrap; margin-bottom: 56px; }\n  .hx-pathway-item { text-align: center; flex: 0 0 180px; padding: 0 10px; }\n  .hx-pathway-icon { width: 56px; height: 56px; border-radius: 50%; background: linear-gradient(135deg, #fdf6ec, #f5e6cc); display: flex; align-items: center; justify-content: center; margin: 0 auto 12px; }\n  .hx-pathway-icon svg { width: 24px; height: 24px; }\n  .hx-pathway-item h4 { font-family: 'Open Sans', sans-serif; font-size: 13px; font-weight: 700; margin-bottom: 6px; color: #1a1a1a; }\n  .hx-pathway-item p { font-size: 16px; line-height: 1.5; }\n  .hx-pathway-arrow { flex: 0 0 30px; display: flex; align-items: center; justify-content: center; padding-top: 16px; color: #C8A876; font-size: 16px; }\n\n  \/* \u2500\u2500 SYMPTOMS \u2500\u2500 *\/\n  .hx-symptoms-box { background: #FAFAF7; border-radius: 12px; padding: 40px 44px; max-width: 1000px; margin: 0 auto; }\n  .hx-symptoms-box h3 { text-align: center; font-size: 26px; margin-bottom: 28px; }\n  .hx-symptom-grid { display: grid; grid-template-columns: repeat(auto-fill, minmax(250px, 1fr)); gap: 12px 30px; }\n  .hx-symptom-tag { display: flex; align-items: center; gap: 8px; font-size: 16px; color: #1a1a1a; font-weight: 300; padding: 6px 0; }\n  .hx-symptom-tag::before { content: ''; display: inline-block; width: 6px; height: 6px; border-radius: 50%; background: #C8A876; flex-shrink: 0; }\n\n  \/* \u2500\u2500 HEALING ROADMAP \u2500\u2500 *\/\n  .hx-roadmap-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 24px; margin-bottom: 24px; }\n  .hx-roadmap-card { background: #fff; border: 1px solid #eee; border-radius: 10px; padding: 32px; overflow: hidden; }\n  .hx-roadmap-card.hx-card-highlight { background: #fdf8f0; border-color: #e8d5b0; }\n  .hx-roadmap-phase { font-family: 'Open Sans', sans-serif; font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1.5px; color: #C8A876; margin-bottom: 12px; display: inline-block; background: rgba(200,168,118,0.1); padding: 3px 10px; border-radius: 4px; }\n  .hx-roadmap-card h3 { font-size: 22px; margin-bottom: 12px; color: #1a1a1a; }\n  .hx-roadmap-card p { font-size: 16px; }\n\n  .hx-roadmap-row3 { display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px; }\n  .hx-roadmap-row3 .hx-roadmap-card h3 { font-size: 20px; }\n\n  .hx-lens-table { width: 100%; margin-top: 16px; border-collapse: collapse; }\n  .hx-lens-table td { padding: 10px; font-family: 'Open Sans', sans-serif; font-size: 16px; font-weight: 300; color: #1a1a1a; border-bottom: 1px solid #f0ebe0; vertical-align: top; }\n  .hx-lens-table td:first-child { font-weight: 700; color: #1a1a1a; width: 140px; }\n\n  \/* \u2500\u2500 SUPPRESSION SECTION \u2500\u2500 *\/\n  .hx-suppression { display: flex; gap: 44px; align-items: center;  flex-wrap: wrap; }\n  .hx-suppression-text { flex: 1; min-width: 300px; }\n  .hx-suppression-text h2 { font-size: 36px; margin-bottom: 24px; line-height: 1.25; }\n  .hx-suppression-text p { margin-bottom: 16px; }\n  .hx-suppression-list { list-style: none; padding: 0; margin: 18px 0; }\n  .hx-suppression-list li { font-family: 'Open Sans', sans-serif; font-size: 16px; font-weight: 300; color: #1a1a1a; padding: 6px 0 6px 18px; position: relative; }\n  .hx-suppression-list li::before { content: ''; position: absolute; left: 0; top: 13px; width: 6px; height: 6px; border-radius: 50%; background: #C8A876; }\n  .hx-suppression-image { flex: 0 0 340px; border-radius: 14px; overflow: hidden; }\n  .hx-suppression-image img { width: 100%; height: 340px; object-fit: cover; display: block; border-radius: 14px; }\n\n  .hx-overlap-box { margin-top: 24px; background: #fdf8f0; border: 1px solid #e8d5b0; border-radius: 10px; padding: 20px 24px; }\n  .hx-overlap-box h4 { font-family: 'Open Sans', sans-serif; font-size: 14px; font-weight: 700; color: #C8A876; margin-bottom: 10px; }\n  .hx-overlap-box p { font-size: 16px; margin: 0; }\n\n  \/* \u2500\u2500 FAQ \u2500\u2500 *\/\n  .hx-faq-section { padding: 70px 0; max-width: 900px; margin: 0 auto; }\n  .hx-faq-section > h2 { text-align: center; font-size: 34px; margin-bottom: 44px; }\n  .hx-faq-item { border-top: 1px solid #ddd; }\n  .hx-faq-item:last-child { border-bottom: 1px solid #ddd; }\n  button.hx-faq-question { display: flex; justify-content: space-between; align-items: center; padding: 24px 4px; cursor: pointer; font-family: 'TT Ramillas Trial Regular', serif; font-size: 18px; font-weight: 700; color: #1a1a1a; background: none; border: none; width: 100%; text-align: left; text-transform: capitalize; letter-spacing: 3px; transition: color 0.3s ease; }\n  .hx-faq-question:hover, .hx-faq-question:focus  { \n      color: #CFA761!important ;\n      background-color: #ffffff!important;\n  }\n  .hx-faq-chevron { font-size: 14px; color: #C8A876; transition: transform 0.3s ease; flex-shrink: 0; margin-left: 20px; }\n  .hx-faq-item.active .hx-faq-chevron { transform: rotate(180deg); }\n  .hx-faq-answer { max-height: 0; overflow: hidden; transition: max-height 0.5s ease; }\n  .hx-faq-answer-inner { padding: 0 4px 24px; }\n  .hx-faq-answer-inner p { font-size: 16px; color: #1a1a1a; font-weight: 300; line-height: 1.8; margin-bottom: 12px; }\n  .hx-faq-item.active .hx-faq-answer { max-height: 600px; }\n\n  \/* \u2500\u2500 CTA \u2500\u2500 *\/\n  .hx-cta-wrapper { margin: 50px -20px 50px; }\n  .hx-cta-section { text-align: center; padding: 70px 40px 80px; background: #fafaf6; border-radius: 20px; }\n  .hx-cta-section h2 { color: black; font-size: 40px; margin-bottom: 20px; }\n  .hx-cta-section p { color: black; font-size: 16px; font-weight: 300; max-width: 600px; margin: 0 auto 30px; }\n  .hx-cta-list { list-style: none; padding: 0; text-align: left; display: inline-block; margin: 0 auto 28px; }\n  .hx-cta-list li { color: black; font-family: 'Open Sans', sans-serif; font-size: 16px; font-weight: 300; padding: 7px 0 7px 24px; position: relative; }\n  .hx-cta-list li::before { content: ''; position: absolute; left: 0; top: 14px; width: 7px; height: 7px; border-radius: 50%; background: #C8A876; }\n  .hx-cta-buttons { display: flex; justify-content: center; gap: 20px; flex-wrap: wrap; }\n  .hx-btn-primary { display: inline-block; background: #C8A876; color: #1a1a1a; font-family: 'Open Sans', sans-serif; font-size: 15px; font-weight: 600; padding: 18px 40px; border-radius: 50px; transition: background 0.3s ease; }\n  .hx-btn-primary:hover { background: #b89560; }\n  .hx-btn-outline { display: inline-block; border: 1px solid #C8A876; color: #C8A876; font-family: 'Open Sans', sans-serif; font-size: 13px; font-weight: 600; padding: 18px 40px; border-radius: 50px; transition: all 0.3s ease;  letter-spacing: normal; text-transform: none; }\n  .hx-btn-outline:hover { background: #C8A876; color: #1a1a1a; }\n\n  \/* \u2500\u2500 PHASE DETAIL SECTIONS \u2500\u2500 *\/\n  .hx-phase-detail { padding: 10px 0; max-width: 100%; margin: 0 auto; }\n  .hx-phase-detail h3 { font-size: 28px; margin-bottom: 10px; }\n  .hx-phase-detail .hx-phase-sub { font-family: 'TT Ramillas Trial Regular', serif; color: #C8A876; font-size: 17px; margin-bottom: 18px; }\n  .hx-phase-detail p { margin-bottom: 14px; }\n  .hx-detail-list { list-style: none; padding: 0; margin: 14px 0; }\n  .hx-detail-list li { font-family: 'Open Sans', sans-serif; font-size: 16px; font-weight: 300; color: #1a1a1a; padding: 6px 0 6px 18px; position: relative; }\n  .hx-detail-list li::before { content: ''; position: absolute; left: 0; top: 13px; width: 6px; height: 6px; border-radius: 50%; background: #C8A876; }\n  .hx-phase-sep { width: 100%; height: 1px; background: #eee; margin: 14px 0; }\n\n  .hx-lens-detail { background: #fafaf7; border-radius: 10px; padding: 24px 28px; margin: 16px 0; }\n  .hx-lens-detail h4 { font-family: 'Open Sans', sans-serif; font-size: 15px; font-weight: 700; color: #1a1a1a; margin-bottom: 10px; }\n  .hx-lens-detail p { font-size: 16px; margin-bottom: 8px; }\n\n  .hx-enr-grid { display: grid; grid-template-columns: repeat(3, 1fr); gap: 18px; margin: 18px 0; }\n  .hx-enr-item { background: #fdf8f0; border-radius: 8px; padding: 18px; text-align: center; }\n  .hx-enr-item strong { display: block; font-size: 15px; color: #C8A876; margin-bottom: 6px; }\n  .hx-enr-item span { font-family: 'Open Sans', sans-serif; font-size: 16px; font-weight: 300; color: #1a1a1a; }\n\n  \/* \u2500\u2500 RESPONSIVE \u2500\u2500 *\/\n  @media (max-width: 768px) {\n    .hx-mcas-hero { flex-direction: column; }\n    .hx-mcas-hero-image { flex: 0 0 auto; width: 100%; }\n    .hx-mcas-hero-image img { height: 350px; }\n    .hx-mcas-hero-text h1 { font-size: 32px; }\n    .hx-section-title { font-size: 26px; }\n    .hx-roadmap-grid { grid-template-columns: 1fr; }\n    .hx-roadmap-row3 { grid-template-columns: 1fr; }\n    .hx-suppression { flex-direction: column; }\n    .hx-suppression-image { flex: 0 0 auto; width: 100%; }\n    .hx-pathway-flow { flex-direction: column; align-items: center; }\n    .hx-pathway-arrow { transform: rotate(90deg); padding: 0; }\n    .hx-pathway-item { flex: 0 0 auto; }\n    .hx-enr-grid { grid-template-columns: 1fr; }\n    .hx-cta-section h2 { font-size: 28px; }\n    .hx-suppression-text h2 { font-size: 26px; }\n    .hx-symptom-grid { grid-template-columns: 1fr 1fr; }\n  }\n<\/style>\n\n<div class=\"hx-mcas\">\n\n  <section class=\"hx-mcas-hero\">\n    <div class=\"hx-mcas-hero-image\">\n      <img decoding=\"async\" src=\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png\" alt=\"Lyme Disease Treatment at Helixona\" style=\"background:#f0ebe0;\">\n    <\/div>\n    <div class=\"hx-mcas-hero-text\">\n      <div class=\"hx-gold-line\"><\/div>\n      <h1>Lyme Disease & <span class=\"hx-accent\">Chronic Co-Infections<\/span><\/h1>\n      <div class=\"hx-subtitle\">Treatment in Irvine, CA<\/div>\n      <p class=\"hx-highlight\">When Infection Becomes a Systems-Level Illness<\/p>\n      <p>Lyme disease is caused by Borrelia burgdorferi, a tick-borne bacterium. When identified and treated early, many patients recover fully.<\/p>\n      <p>However, when diagnosis is delayed \u2014 or when additional stressors are present \u2014 some individuals experience persistent, multi-system symptoms that extend beyond the initial infection.<\/p>\n      <p class=\"hx-highlight\">At Helixona, we approach Lyme and co-infections within a structured systems model.<\/p>\n      <p>We do not treat infection in isolation. We evaluate how infection interacts with immune regulation, mitochondrial function, toxin burden, and nervous system stability. Persistent symptoms are not random. They are patterned.<\/p>\n    <\/div>\n  <\/section>\n\n  <section class=\"hx-section\">\n    <h2 class=\"hx-section-title\">Understanding <span class=\"hx-accent\">Lyme & Co-Infections<\/span><\/h2>\n\n    <div class=\"hx-develops-intro\">\n      <p>Ticks may transmit multiple organisms, including Borrelia burgdorferi, Babesia, Bartonella, Ehrlichia, Anaplasma, and Rickettsial species. Each organism affects the body differently. Some influence red blood cells. Others affect vascular tissue or the nervous system.<\/p>\n      <p>When Lyme is treated promptly in its early stage, immune clearance is typically effective. When diagnosis is delayed, several biological shifts may occur:<\/p>\n    <\/div>\n\n    <div class=\"hx-pathway-flow\">\n      <div class=\"hx-pathway-item\">\n        <div class=\"hx-pathway-icon\">\n          <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"#C8A876\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M12 2v4m0 12v4M4.93 4.93l2.83 2.83m8.48 8.48l2.83 2.83M2 12h4m12 0h4M4.93 19.07l2.83-2.83m8.48-8.48l2.83-2.83\"\/><\/svg>\n        <\/div>\n        <h4>Deeper Migration<\/h4>\n        <p>Organisms migrate into connective tissue, joints, and nervous system structures.<\/p>\n      <\/div>\n      <div class=\"hx-pathway-arrow\">\u2192<\/div>\n      <div class=\"hx-pathway-item\">\n        <div class=\"hx-pathway-icon\">\n          <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"#C8A876\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M13 2L3 14h9l-1 8 10-12h-9l1-8z\"\/><\/svg>\n        <\/div>\n        <h4>Biofilm & Immunity<\/h4>\n        <p>Bacteria form biofilms; prolonged infection alters cytokine signaling and immune balance.<\/p>\n      <\/div>\n      <div class=\"hx-pathway-arrow\">\u2192<\/div>\n      <div class=\"hx-pathway-item\">\n        <div class=\"hx-pathway-icon\">\n          <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"#C8A876\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 6v6l4 2\"\/><\/svg>\n        <\/div>\n        <h4>Metabolic Strain<\/h4>\n        <p>Chronic inflammatory burden increases oxidative stress, impairing mitochondria.<\/p>\n      <\/div>\n      <div class=\"hx-pathway-arrow\">\u2192<\/div>\n      <div class=\"hx-pathway-item\">\n        <div class=\"hx-pathway-icon\">\n          <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"#C8A876\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><rect x=\"2\" y=\"7\" width=\"20\" height=\"10\" rx=\"2\"\/><path d=\"M6 7v10m4-10v10m4-10v10m4-10v10\"\/><\/svg>\n        <\/div>\n        <h4>Autonomic Imprinting<\/h4>\n        <p>Extended illness dysregulates autonomic tone and heightened stress reactivity.<\/p>\n      <\/div>\n      <div class=\"hx-pathway-arrow\">\u2192<\/div>\n      <div class=\"hx-pathway-item\">\n        <div class=\"hx-pathway-icon\">\n          <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"#C8A876\" stroke-width=\"1.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z\"\/><\/svg>\n        <\/div>\n        <h4>Persistent Symptoms<\/h4>\n        <p>Multiple burdens increase complexity, leading to fluctuating symptoms.<\/p>\n      <\/div>\n    <\/div>\n\n    <div class=\"hx-symptoms-box\">\n      <h3>Common <span class=\"hx-accent\">Symptoms<\/span><\/h3>\n      <p style=\"text-align:center; margin-bottom:24px;\">Symptoms are often fluctuating and multi-system. They may include:<\/p>\n      <div class=\"hx-symptom-grid\">\n        <div class=\"hx-symptom-tag\">Persistent fatigue<\/div>\n        <div class=\"hx-symptom-tag\">Brain fog<\/div>\n        <div class=\"hx-symptom-tag\">Migratory joint or muscle pain<\/div>\n        <div class=\"hx-symptom-tag\">Neuropathy<\/div>\n        <div class=\"hx-symptom-tag\">Headaches<\/div>\n        <div class=\"hx-symptom-tag\">Anxiety or mood instability<\/div>\n        <div class=\"hx-symptom-tag\">Temperature dysregulation<\/div>\n        <div class=\"hx-symptom-tag\">Sleep disturbance<\/div>\n        <div class=\"hx-symptom-tag\">Autonomic instability<\/div>\n        <div class=\"hx-symptom-tag\">Mast cell reactivity<\/div>\n      <\/div>\n    <\/div>\n  <\/section>\n\n  <section class=\"hx-section\">\n    <h2 class=\"hx-section-title\">Where Lyme Fits in the <span class=\"hx-accent\">Helixona Healing Roadmap<\/span><\/h2>\n    <p style=\"text-align:center; max-width:650px; margin:-20px auto 36px; font-size:15px; color:#777;\">Lyme is evaluated within a structured sequence.<\/p>\n\n    <div class=\"hx-roadmap-grid\">\n      <div class=\"hx-roadmap-card\">\n        <span class=\"hx-roadmap-phase\">Phase 1<\/span>\n        <h3>Anchoring Your <span class=\"hx-accent\">Why<\/span><\/h3>\n        <p>Chronic Lyme symptoms can be discouraging. Before testing begins, we clarify your Why. Recovery often requires sequencing and patience. Your Why anchors the process during difficult phases.<\/p>\n      <\/div>\n\n      <div class=\"hx-roadmap-card hx-card-highlight\">\n        <span class=\"hx-roadmap-phase\">Phase 2<\/span>\n        <h3>Identification: The <span class=\"hx-accent\">Four-Lens<\/span> Evaluation<\/h3>\n        <table class=\"hx-lens-table\">\n          <tr><td>Neurological<\/td><td>Autonomic stability, neuroinflammatory patterns, vagal tone, stress imprinting<\/td><\/tr>\n          <tr><td>Electrical<\/td><td>Cellular membrane stability and voltage (correlates with fatigue\/cognitive symptoms)<\/td><\/tr>\n          <tr><td>Biochemical<\/td><td>Lyme serology, co-infection panels, inflammatory\/immune markers, mold\/toxins<\/td><\/tr>\n          <tr><td>Clinical Mapping<\/td><td>Tick exposure, onset timing, flare patterns, antibiotic response, co-existing conditions<\/td><\/tr>\n        <\/table>\n      <\/div>\n    <\/div>\n\n    <div class=\"hx-roadmap-row3\">\n      <div class=\"hx-roadmap-card\">\n        <span class=\"hx-roadmap-phase\">Phase 3<\/span>\n        <h3>Stabilization<\/h3>\n        <p>Preparing the system before aggressive therapy. Aggressive antimicrobial therapy in an unstable patient can trigger inflammatory flare responses.<\/p>\n      <\/div>\n\n      <div class=\"hx-roadmap-card\">\n        <span class=\"hx-roadmap-phase\">Phase 4<\/span>\n        <h3>Addressing Infection in Sequence<\/h3>\n        <p>Once stabilized, we address Lyme and co-infections strategically. Treatment proceeds in layers. Lyme may be first \u2014 but not always.<\/p>\n      <\/div>\n\n      <div class=\"hx-roadmap-card\">\n        <span class=\"hx-roadmap-phase\">Integration<\/span>\n        <h3>Lyme & <span class=\"hx-accent\">Overlapping Conditions<\/span><\/h3>\n        <p>Treating only infection without addressing overlapping burdens like mold, MCAS, or POTS may limit improvement. Sequencing determines outcome.<\/p>\n      <\/div>\n    <\/div>\n  <\/section>\n\n  <div class=\"hx-phase-detail\">\n    <div class=\"hx-phase-sep\"><\/div>\n    <span class=\"hx-roadmap-phase\">Phase 1<\/span>\n    <h3>Anchoring Your <span class=\"hx-accent\">Why<\/span><\/h3>\n    <p>Chronic Lyme symptoms can be discouraging.<\/p>\n    <p>Before testing begins, we clarify your Why. Recovery often requires sequencing and patience.<\/p>\n    <p style=\"font-weight:600; color:#2D2D2D;\">Your Why anchors the process during difficult phases.<\/p>\n  <\/div>\n\n  <div class=\"hx-phase-detail\">\n    <div class=\"hx-phase-sep\"><\/div>\n    <span class=\"hx-roadmap-phase\">Phase 2<\/span>\n    <h3>Identification: <span class=\"hx-accent\">Determining Whether Lyme Is the Primary Lead Actor<\/span><\/h3>\n    <p>Lyme may be the dominant driver, one of multiple interacting contributors, or secondary to mold or toxin burden. We evaluate through our Four-Lens model:<\/p>\n\n    <div class=\"hx-lens-detail\">\n      <h4>Neurological System Assessment<\/h4>\n      <p>We assess autonomic stability, neuroinflammatory patterns, vagal tone, and stress imprinting. Lyme frequently influences both central and peripheral nervous system function.<\/p>\n    <\/div>\n\n    <div class=\"hx-lens-detail\">\n      <h4>Electrical System Assessment (MEAD Analysis)<\/h4>\n      <p>Chronic infection increases oxidative stress, which can impair cellular membrane stability and voltage. Electrical instability often correlates with fatigue and cognitive symptoms.<\/p>\n    <\/div>\n\n    <div class=\"hx-lens-detail\">\n      <h4>Biochemical &amp; Laboratory Evaluation<\/h4>\n      <p>Testing may include Lyme serology, co-infection panels, inflammatory markers, immune markers, mold and toxin burden, and hormonal and mitochondrial markers. Accurate identification prevents overtreatment and mis-sequencing.<\/p>\n    <\/div>\n\n    <div class=\"hx-lens-detail\">\n      <h4>Clinical Mapping &amp; Symptom Sequencing<\/h4>\n      <p>We analyze tick exposure history, onset timing, flare patterns, response to prior antibiotics, environmental exposures, and co-existing MCAS, POTS, or fatigue patterns. Patterns guide order of care.<\/p>\n    <\/div>\n  <\/div>\n\n  <div class=\"hx-phase-detail\">\n    <div class=\"hx-phase-sep\"><\/div>\n    <span class=\"hx-roadmap-phase\">Phase 3<\/span>\n    <h3>Stabilization<\/h3>\n    <div class=\"hx-phase-sub\">Preparing the System Before Aggressive Therapy<\/div>\n    <p>Aggressive antimicrobial therapy in an unstable patient can trigger inflammatory flare responses. Stabilization may include:<\/p>\n    <ul class=\"hx-detail-list\">\n      <li>Nervous system regulation<\/li>\n      <li>Mast cell stabilization<\/li>\n      <li>Mitochondrial support<\/li>\n      <li>Sleep restoration<\/li>\n      <li>Electrolyte optimization<\/li>\n      <li>Gentle detox pathway support<\/li>\n    <\/ul>\n    <p>Stability improves tolerance and reduces setbacks.<\/p>\n  <\/div>\n\n  <div class=\"hx-phase-detail\">\n    <div class=\"hx-phase-sep\"><\/div>\n    <span class=\"hx-roadmap-phase\">Phase 4<\/span>\n    <h3>Addressing Infection <span class=\"hx-accent\">in Sequence<\/span><\/h3>\n    <p>Once stabilized, we address Lyme and co-infections strategically. We integrate:<\/p>\n\n    <div class=\"hx-enr-grid\">\n      <div class=\"hx-enr-item\">\n        <strong>ELIMINATE<\/strong>\n        <span>Reduce microbial burden and inflammatory load.<\/span>\n      <\/div>\n      <div class=\"hx-enr-item\">\n        <strong>NOURISH<\/strong>\n        <span>Restore mitochondrial capacity and nutrient depletion.<\/span>\n      <\/div>\n      <div class=\"hx-enr-item\">\n        <strong>REPAIR<\/strong>\n        <span>Rebuild neurological and immune regulation.<\/span>\n      <\/div>\n    <\/div>\n\n    <p>Treatment proceeds in layers: Lead Actor 1 \u2192 Lead Actor 2 \u2192 Lead Actor 3.<\/p>\n    <p style=\"font-weight:600;\">Lyme may be first \u2014 but not always.<\/p>\n  <\/div>\n\n  <section class=\"hx-section\">\n    <div class=\"hx-suppression\">\n      <div class=\"hx-suppression-text\">\n        <h2>Chronic Lyme vs. <span class=\"hx-accent\">Post-Treatment Lyme Symptoms<\/span><\/h2>\n        <p>Terminology in this field can be confusing. Some patients are described as having \"Chronic Lyme disease\", \"Post-treatment Lyme disease syndrome\", or \"Persistent Lyme symptoms\".<\/p>\n        <p>Regardless of terminology, the clinical reality is that some individuals experience ongoing symptoms after Lyme infection. At Helixona, our focus is not on labels. It is on identifying what is currently driving dysfunction.<\/p>\n        \n        <div class=\"hx-overlap-box\">\n          <h4>Why Early Treatment Matters & Overlapping Burdens<\/h4>\n          <p>Delayed treatment does not guarantee chronic illness. But it can change the biological terrain. In some cases, Lyme coexists with mold exposure, heavy metals, or other toxic stressors. Lyme frequently overlaps with Mold illness, MCAS, POTS, Chronic fatigue, Autoimmune activation, and Ehlers-Danlos Syndrome. Multiple burdens increase complexity.<\/p>\n        <\/div>\n      <\/div>\n      <div class=\"hx-suppression-image\">\n        <img decoding=\"async\" src=\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/bg-energetics.png\" alt=\"Helixona Diagnostics\" style=\"width:100%; height:340px; object-fit:cover; border-radius:14px; background:#f0ebe0;\">\n      <\/div>\n    <\/div>\n  <\/section>\n\n  <section class=\"hx-faq-section\">\n    <h2>Frequently Asked <span class=\"hx-accent\">Questions<\/span><\/h2>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Is chronic Lyme disease real?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Some patients experience persistent symptoms after Lyme infection, even after standard treatment. Terminology varies \u2014 some use \u201cchronic Lyme disease,\u201d while others use \u201cpost-treatment Lyme disease syndrome.\u201d<\/p>\n        <p>What is clear is that ongoing symptoms can occur. These symptoms may involve immune dysregulation, neuroinflammation, autonomic instability, mitochondrial strain, or co-infections. At Helixona, we focus less on terminology and more on identifying the current drivers of dysfunction.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Why do some people recover quickly while others do not?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Recovery depends on multiple factors, including timing of diagnosis, early treatment response, presence of co-infections, immune system resilience, environmental toxin exposure, genetic susceptibility, mitochondrial capacity, and nervous system regulation.<\/p>\n        <p>Delayed treatment can allow deeper tissue migration and prolonged immune activation, which may complicate recovery.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Can Lyme hide in the body?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Borrelia organisms are capable of migrating into connective tissue and nervous system structures. Some research suggests bacteria may form protective biofilm communities that reduce immune recognition.<\/p>\n        <p>Whether persistent symptoms reflect active infection, immune dysregulation, or both varies by individual. This is why structured evaluation is essential.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Why are Lyme tests sometimes negative?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Standard Lyme testing measures antibody response. If immune signaling is altered, suppressed, or delayed, antibody levels may not reflect active or past infection accurately.<\/p>\n        <p>Additionally, timing of testing and laboratory methodology influence results. Clinical history and pattern recognition remain important components of evaluation.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        What are co-infections and why do they matter?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Ticks may transmit multiple organisms simultaneously. Co-infections such as Babesia or Bartonella can produce symptoms that differ from classic Lyme and may require different therapeutic approaches.<\/p>\n        <p>If co-infections are not identified, improvement may plateau.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Why do symptoms flare during treatment?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>When microbial burden decreases, inflammatory mediators may temporarily increase \u2014 sometimes referred to as a \u201cHerxheimer reaction.\u201d<\/p>\n        <p>Additionally, aggressive treatment in an unstable system can amplify immune and autonomic reactivity. Stabilization before intensive therapy reduces flare severity.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Can Lyme trigger autoimmune disease?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Prolonged infection can alter immune signaling patterns. In some individuals, this may contribute to autoimmune-like activation or persistent inflammatory states.<\/p>\n        <p>This does not mean all autoimmune disease is caused by Lyme, but infection can be one of several contributors in certain cases.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        How is Lyme connected to mold illness?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Mold exposure can impair detox pathways and immune regulation. If mold and Lyme coexist, immune burden increases.<\/p>\n        <p>In some patients, mold must be addressed before infection treatment becomes effective. Sequencing matters.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Why do I have POTS or MCAS along with Lyme?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Chronic infection increases inflammatory signaling and oxidative stress. This can influence autonomic regulation (leading to POTS patterns), mast cell stability, sleep architecture, and mitochondrial efficiency.<\/p>\n        <p>Lyme is often one piece of a larger systems interaction.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        Can Lyme be completely cured?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>Many patients recover fully with early treatment. In cases of persistent symptoms, improvement depends on identifying current drivers \u2014 whether infection, immune dysregulation, toxin burden, mitochondrial strain, or autonomic instability.<\/p>\n        <p>The goal is not only microbial reduction, but restoration of system regulation.<\/p>\n      <\/div><\/div>\n    <\/div>\n\n    <div class=\"hx-faq-item\">\n      <button class=\"hx-faq-question\" onclick=\"this.parentElement.classList.toggle('active')\">\n        What is the first step if I suspect persistent Lyme symptoms?\n        <span class=\"hx-faq-chevron\">\u25be<\/span>\n      <\/button>\n      <div class=\"hx-faq-answer\"><div class=\"hx-faq-answer-inner\">\n        <p>The first step is identification. Determine: Is infection still a dominant Lead Actor? Are co-infections present? Is mold or toxin burden contributing? Is mitochondrial support needed? Is autonomic dysregulation present?<\/p>\n        <p>Once drivers are clarified, treatment can proceed in sequence.<\/p>\n      <\/div><\/div>\n    <\/div>\n  <\/section>\n\n  <div class=\"hx-cta-wrapper\">\n  <section class=\"hx-cta-section\">\n    <h2>When to Consider a <span class=\"hx-accent\">Comprehensive<br>Evaluation<\/span><\/h2>\n    <p>You may benefit from structured evaluation if:<\/p>\n    <ul class=\"hx-cta-list\">\n      <li>Symptoms began after tick exposure<\/li>\n      <li>You were treated but never felt fully restored<\/li>\n      <li>Fatigue and cognitive symptoms persist<\/li>\n      <li>Symptoms fluctuate in cycles<\/li>\n      <li>You carry overlapping diagnoses<\/li>\n      <li>Standard testing has been inconclusive<\/li>\n    <\/ul>\n    <p style=\"margin-bottom:36px; font-weight:600;\">Persistent symptoms require systems clarity.<\/p>\n    <div class=\"hx-cta-buttons\">\n      <a href=\"https:\/\/helixona.com\/staging\/booking\/\" class=\"hx-btn-primary\">Schedule Your Evaluation<\/a>\n      <a href=\"https:\/\/helixona.com\/staging\/energetics\/\" class=\"hx-btn-outline\">Learn More About Our Process<\/a>\n    <\/div>\n  <\/section>\n  <\/div>\n\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Lyme Disease &amp; Chronic Co-Infections symptoms we treat Lyme Disease &#038; Chronic Co-Infections Treatment in Irvine, CA When Infection Becomes a Systems-Level Illness Lyme disease is caused by Borrelia burgdorferi, a tick-borne bacterium. When identified and treated early, many patients recover fully. However, when diagnosis is delayed \u2014 or when additional stressors are present \u2014 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-6772","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lyme Disease &amp; Chronic Co-Infections - Helixona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lyme Disease &amp; Chronic Co-Infections - Helixona\" \/>\n<meta property=\"og:description\" content=\"Lyme Disease &amp; Chronic Co-Infections symptoms we treat Lyme Disease &#038; Chronic Co-Infections Treatment in Irvine, CA When Infection Becomes a Systems-Level Illness Lyme disease is caused by Borrelia burgdorferi, a tick-borne bacterium. When identified and treated early, many patients recover fully. However, when diagnosis is delayed \u2014 or when additional stressors are present \u2014 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Helixona\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T16:47:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/\",\"url\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/\",\"name\":\"Lyme Disease &amp; Chronic Co-Infections - Helixona\",\"isPartOf\":{\"@id\":\"https:\/\/helixona.com\/staging\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png\",\"datePublished\":\"2026-03-03T16:55:41+00:00\",\"dateModified\":\"2026-04-02T16:47:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#primaryimage\",\"url\":\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png\",\"contentUrl\":\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png\",\"width\":1414,\"height\":1046},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/helixona.com\/staging\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lyme Disease &amp; Chronic Co-Infections\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/helixona.com\/staging\/#website\",\"url\":\"https:\/\/helixona.com\/staging\/\",\"name\":\"Helixona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/helixona.com\/staging\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/helixona.com\/staging\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/helixona.com\/staging\/#organization\",\"name\":\"Helixona\",\"url\":\"https:\/\/helixona.com\/staging\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/helixona.com\/staging\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2025\/08\/Helixona-Logo-e1755268462823.png\",\"contentUrl\":\"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2025\/08\/Helixona-Logo-e1755268462823.png\",\"width\":2084,\"height\":493,\"caption\":\"Helixona\"},\"image\":{\"@id\":\"https:\/\/helixona.com\/staging\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lyme Disease &amp; Chronic Co-Infections - Helixona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Lyme Disease &amp; Chronic Co-Infections - Helixona","og_description":"Lyme Disease &amp; Chronic Co-Infections symptoms we treat Lyme Disease &#038; Chronic Co-Infections Treatment in Irvine, CA When Infection Becomes a Systems-Level Illness Lyme disease is caused by Borrelia burgdorferi, a tick-borne bacterium. When identified and treated early, many patients recover fully. However, when diagnosis is delayed \u2014 or when additional stressors are present \u2014 [&hellip;]","og_url":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/","og_site_name":"Helixona","article_modified_time":"2026-04-02T16:47:32+00:00","og_image":[{"url":"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/","url":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/","name":"Lyme Disease &amp; Chronic Co-Infections - Helixona","isPartOf":{"@id":"https:\/\/helixona.com\/staging\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#primaryimage"},"image":{"@id":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png","datePublished":"2026-03-03T16:55:41+00:00","dateModified":"2026-04-02T16:47:32+00:00","breadcrumb":{"@id":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#primaryimage","url":"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png","contentUrl":"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2026\/03\/lab.png","width":1414,"height":1046},{"@type":"BreadcrumbList","@id":"https:\/\/helixona.com\/staging\/lyme-disease-chronic-co-infections-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helixona.com\/staging\/"},{"@type":"ListItem","position":2,"name":"Lyme Disease &amp; Chronic Co-Infections"}]},{"@type":"WebSite","@id":"https:\/\/helixona.com\/staging\/#website","url":"https:\/\/helixona.com\/staging\/","name":"Helixona","description":"","publisher":{"@id":"https:\/\/helixona.com\/staging\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helixona.com\/staging\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/helixona.com\/staging\/#organization","name":"Helixona","url":"https:\/\/helixona.com\/staging\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/helixona.com\/staging\/#\/schema\/logo\/image\/","url":"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2025\/08\/Helixona-Logo-e1755268462823.png","contentUrl":"https:\/\/helixona.com\/staging\/wp-content\/uploads\/2025\/08\/Helixona-Logo-e1755268462823.png","width":2084,"height":493,"caption":"Helixona"},"image":{"@id":"https:\/\/helixona.com\/staging\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/pages\/6772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/comments?post=6772"}],"version-history":[{"count":11,"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/pages\/6772\/revisions"}],"predecessor-version":[{"id":7889,"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/pages\/6772\/revisions\/7889"}],"wp:attachment":[{"href":"https:\/\/helixona.com\/staging\/wp-json\/wp\/v2\/media?parent=6772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}